Two players from Austrian champion Salzburg have failed doping tests after returning from international duty with Mali last month.
Midfielder Mohamed Camara and forward Sekou Koita reported being given medication for altitude sickness before an away game against Namibia on Nov. 17 in qualifying for the African Cup of Nations, Salzburg said on Tuesday.
They tested positive on Nov. 22 in Austria in UEFA testing ahead of a Champions League defeat to Bayern Munich, the club said.
Salzburg didn't name the banned substance in question but said it was "a key ingredient" in the altitude sickness medication the players were allegedly given.
Salzburg said it supports the players and wants to clear up what happened while the players were with the national team.
"We are very proud when our players are called up to their national teams. For a full international match, you have to expect though that medical work will conform to international standards, with doctors who are familiar with the rules," Salzburg general manager Stephan Reiter said in a statement.
Camara and Koita have played regularly for Salzburg since the date of the positive test.
UEFA did not immediately respond to a request for comment.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)